Virtus Investment Advisers’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$383K	Sell	42,730 -4,509	-10%	-$40.4K	0.13%	230
2025 Q1	$354K	Buy	+47,239	New	+$354K	0.1%	226
2023 Q1	–	Sell	-23,910	Closed	-$274K	–	281
2022 Q4	$274K	Sell	23,910 -17,798	-43%	-$204K	0.18%	159
2022 Q3	$526K	Buy	+41,708	New	+$526K	0.24%	80